Xynomic Pharma acquires global exclusive rights for Boehringer Ingelheim's cancer drug

Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company has announced that it has bee...

December 26, 2018 | Wednesday | News
I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...

December 24, 2018 | Monday | Company results
Xynomic acquires cancer candidate from Boehringer for $800 M

Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company, has been granted an exclusiv...

December 21, 2018 | Friday | News
Gan & Lee enters into licensing agreement for insulin analogs

Gan & Lee Pharmaceuticals (Gan & Lee), an industry leading biopharmaceutical company with 20 years’ experi...

December 20, 2018 | Thursday | News
Align reaches 6M Invisalign patient milestone from China

Singapore - Align Technology announced that over 6 million patients have begun treatment with Invisalign - the most...

December 19, 2018 | Wednesday | News
Pall opens Biotech integrated solutions Centre in China

Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a ...

December 19, 2018 | Wednesday | News
Cellular Biomedicine Group Appoints CAR-T Pioneer as Member of Scientific Advisory Board

  Cellular Biomedicine Group, a biopharmaceutical firm engaged in the development of immunothera...

December 18, 2018 | Tuesday | News
FibroGen's roxadustat OK'd in China

Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...

December 18, 2018 | Tuesday | News
2019 ENMORE BIO CONFERENCE set to host biotech industry in China

Singapore - 2019 ENMORE BIO CONFERENE will be held on 1st-3rd, March, 2019 in Nanjing Young Cultural Center, Nanjing, Ch...

December 18, 2018 | Tuesday | News
Mobidiag announces JV with Autobio Diagnostics

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, has e...

December 18, 2018 | Tuesday | News
I-Mab partners with CSPC for long-acting GLP-1 Fc Program

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company focused on the development of innov...

December 17, 2018 | Monday | News
bioLIVE China 2019 to lead Bio-Pharma technology in Asia

The bio-pharma display platform with 7 years of experience in China, BioPh China, will be newly...

December 17, 2018 | Monday | News
Innovent, Incyte collaborate for 3 clinical stage products

Innovent Biologics, Inc. and Incyte have entered into a strategic collaboration agreement for three clinical-stage produ...

December 17, 2018 | Monday | News
Lonza to establish new base in China using GE healthcare solution

Lonza has announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza...

December 14, 2018 | Friday | News
Innovent declares positive result of IBI305, biosimilar to Avastin

Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commerci...

December 13, 2018 | Thursday | News
Cathay Biotech expands production capacity for new Bio-based materials

The government of the city of Wusu (Xinjiang, China) and Cathay Industrial Biotech Co., Ltd. ("Cathay") signed an a...

December 13, 2018 | Thursday | News
OUE Lippo, CMG to develop and operate international hospital in China

Singapore – OUE Lippo Healthcare Limited announced that it has entered into a non-binding letter of intent wi...

December 12, 2018 | Wednesday | News
Huakang Biomed declares allotment results of the Share Offer

Huakang Biomedical Holdings Company Limited is pleased to announce the Offer Price and allotment results of the Share Of...

December 12, 2018 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls